Glioma oncoprotein Bc12L12 inhibits the p53 tumor suppressor

Alexander H. Stegh, Cameron Brennan, John A. Mahoney, Kristin L. Forloney, Harry T. Jenq, Janina P. Luciano, Alexei Protopopov, Lynda Chin, Ronald A. DePinho

Research output: Contribution to journalArticlepeer-review

73 Scopus citations


Glioblastoma multiforme (GBM) is a lethal brain tumor characterized by intense apoptosis resistance and extensive necrosis. Bcl2L12 (for Bcl2-like 12) is a cytoplasmic and nuclear protein that is overexpressed in primary GBM and functions to inhibit post-mitochondrial apoptosis signaling. Here, we show that nuclear Bcl2L12 physically and functionally interacts with the p53 tumor suppressor, as evidenced by the capacity of Bcl2L12 to (1) enable bypass of replicative senescence without concomitant loss of p53 or p19Arf, (2) inhibit p53-dependent DNA damage-induced apoptosis, (3) impede the capacity of p53 to bind some of its target gene promoters, and (4) attenuate endogenous p53-directed transcriptomic changes following genotoxic stress. Correspondingly, The Cancer Genome Atlas profile and tissue protein analyses of human GBM specimens show significantly lower Bcl2L12 expression in the setting of genetic p53 pathway inactivation. Thus, Bcl2L12 is a multifunctional protein that contributes to intense therapeutic resistance of GBM through its ability to operate on two key nodes of cytoplasmic and nuclear signaling cascades.

Original languageEnglish (US)
Pages (from-to)2194-2204
Number of pages11
JournalGenes and Development
Issue number19
StatePublished - Oct 1 2010


  • Bc12L12
  • Glioblastoma multiforme
  • p53

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology


Dive into the research topics of 'Glioma oncoprotein Bc12L12 inhibits the p53 tumor suppressor'. Together they form a unique fingerprint.

Cite this